Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01639482 · ClinicalTrials.gov registry record
Neuroimaging Studies of the Treatment of Bipolar Depression With Citalopram
A clinical trial of Bipolar Depression, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT01639482: Completed study of Bipolar Depression, sponsored by Massachusetts General Hospital.
NCT01639482 is a study of Bipolar Depression that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 214-participant average among 29 other Bipolar Depression trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01639482, a study of Bipolar Depression, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Regional metabolic changes associated with response to 6 weeks of citalopram treatment, using 18-Fluorodeoxyglucose Positron Emission Tomography imaging, will be characterized (FDG PET).
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - East - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-04 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01639482
The ClinicalTrials.gov registry entry for NCT01639482 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 214-participant average among 29 other Bipolar Depression trials with a reported enrollment target (72% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar Depression appearing as the primary indexed condition, and to 0 interventions.
NCT01639482 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01639482 about?
NCT01639482 is a clinical study titled "Neuroimaging Studies of the Treatment of Bipolar Depression With Citalopram". Regional metabolic changes associated with response to 6 weeks of citalopram treatment, using 18-Fluorodeoxyglucose Positron Emission Tomography imaging, will be characterized (FDG PET).
What is the current status of trial NCT01639482?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2010-04. Estimated completion is 2013-12.
What conditions does trial NCT01639482 study?
This clinical trial studies the following conditions: Bipolar Depression.
Who is sponsoring clinical trial NCT01639482?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01639482 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
RECRUITING · Phase 3
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
Ketogenic Intervention for Bipolar Depression
RECRUITING · NA
-
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
RECRUITING · Phase 4
-
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
RECRUITING · Phase 3
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.